CIK 0000025743
- Non-accelerated filer
- Smaller reporting company
TherapeuticsMD, Inc.
Sign in to watch- Ticker
- TXMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 870233535
- Phone
- +1 561-961-1900
- Business address
- 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
- Former names
- AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 312,525 shares (grant or award)
- 4/A Open-market sale Chief Executive Officer sold 692 shares at $3.64 ($2,518)
- 4 Open-market sale Chief Executive Officer sold 1,170 shares at $3.65 ($4,276)
- 4 Exercise or conversion Prin. Fin. and Acctg. Officer acquired 50,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Returned to the company Director returned 29,000 shares (to the company)
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale Prin. Fin. and Acctg. Officer sold 1,697 shares at an average $5.08 ($8,621)
- 4 Open-market sale Prin. Fin. and Acctg. Officer sold 1,309 shares at an average $5.34 ($6,988)
- 4 Open-market sale 10% owner sold 29,000 shares at $1,333.00 ($38,657,000)
- 4 Open-market buy 10% owner bought 14,825 shares at $6.09 ($90,284)
- 4 Open-market sale Co-Chief Executive Officer sold 1,255 shares at an average $5.28 ($6,621)
- 4 Open-market sale General Counsel sold 1,048 shares at $4.95 ($5,185)
- 4 Open-market sale Co-Chief Executive Officer sold 440 shares at $4.92 ($2,165)
- 4 Open-market sale Interim CFO/CAO/VP of Finance sold 910 shares at $4.78 ($4,345)
- 4 Open-market buy 10% owner bought 20,413 shares at an average $5.66 ($115,639)
- 4 Open-market sale Director sold 3,922 shares at $5.26 ($20,635)
- 4 Open-market buy 10% owner bought 7,000 shares at $1,000.00 ($7,000,000)
Page 2 of 22 · 428 filings